Clinical Trials Directory

Trials / Unknown

UnknownNCT03729713

Computerized Cognitive Rehabilitation in MS Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study examines a home-based computerized cognitive rehabilitation intervention in adults with multiple sclerosis compared to placebo (videogame). Patients are assessed through pre-and post neuropsychological testing.

Detailed description

Patients will be randomized to enter a 6 week course of computer based cognitive rehabilitation focused on improving attention, learning, and memory. Control patients will receive an alternative home-based computer program not designed for cognitive remediation but of the same duration. The primary outcome will be performance on neuropsychological testing in the intervention sample compared to controls. Secondary outcomes will be the measures of self-efficacy, work productivity, quality of life, fatigue, depression, anxiety, and healthcare utilization. Healthcare utilization variables include annual total cost (current year and prior), number and cost of ER/hospital/outpatient visits, number of hospital visits, hospital length of stay, number preventive visits, total number claims, and number of new medications initiated. In addition, acute changes in neuropsychological testing induced by a bout of physical activity (i.e. self-paced walking during the Six-Minute Walk Test) will be examined, and that pattern of change will be compared between intervention and control groups at each data collection point. Each subject will participate for a total of 6 months.

Conditions

Interventions

TypeNameDescription
OTHERComputerized cognitive rehabilitation6 week course of cognitive rehabilitation focused on attention, learning, and memory
OTHERSham placeboan alternative home-based computer program not designed for cognitive remediation but of the same duration

Timeline

Start date
2021-04-21
Primary completion
2023-05-01
Completion
2024-05-01
First posted
2018-11-05
Last updated
2022-11-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03729713. Inclusion in this directory is not an endorsement.